PCCIR53 Stock Latest News
Private CompaniesCircular Genomics Highlights CircRNA Biomarker Data in Alzheimer’s Research17h agoCIR53
Private CompaniesCircRNA Biomarkers Show Potential for Earlier Alzheimer’s Detection17h agoCIR53
Private CompaniesCircular Genomics Introduces CircRNA Research Platform for Precision Neurology1w agoCIR53
Private CompaniesCircular Genomics to Present Five Alzheimer’s Biomarker Studies at CTAD 20261w agoCIR53
Private CompaniesCircular Genomics to Present Five Alzheimer’s Biomarker Studies at CTAD 20261w agoCIR53Private CompaniesCircular Genomics and PharmatrophiX Collaborate on Neurodegeneration Research2w agoCIR53
Private CompaniesR&D Talent Spotlight Underscores Circular Genomics’ Focus on circRNA Biomarker Platform3w agoCIR53
Private CompaniesCircular Genomics Highlights Alzheimer’s Biomarker Research Ahead of CTAD 20263w agoCIR53
Private CompaniesCircular Genomics Highlights Alzheimer’s Biomarker Focus at BioChallenge 20263w agoCIR53
Private CompaniesCircular Genomics Highlights Strategic Focus on Brain and Mental Health1M agoCIR53
Private CompaniesCircular Genomics Leadership Underscores Commercialization Focus at LSI Europe1M agoCIR53
Private CompaniesCircular Genomics Highlights Neurology Biomarker Focus at LSI Europe ’261M agoCIR53
Private CompaniesCircular Genomics Highlights Focus on Early Detection in Alzheimer’s Research2M agoCIR53
Private CompaniesCircular Genomics Highlights Blood-Based circRNA Biomarkers for Alzheimer’s Research3M agoCIR53
Private CompaniesAlzheimer’s Biomarker Research From Circular Genomics Receives Academic Spotlight3M agoCIR53
Private CompaniesNature Recognition Elevates Circular Genomics’ Alzheimer’s Research Profile3M agoCIR53



